ID   KCC1D_HUMAN             Reviewed;         385 AA.
AC   Q8IU85; B0YIY0; Q9HD31;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   15-MAR-2017, entry version 145.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1D;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I delta;
DE            Short=CaM kinase ID;
DE            Short=CaM-KI delta;
DE            Short=CaMKI delta;
DE            Short=CaMKID;
DE   AltName: Full=CaMKI-like protein kinase;
DE            Short=CKLiK;
GN   Name=CAMK1D; Synonyms=CAMKID;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION IN PHOSPHORYLATION OF
RP   CREM AND ACTIVATION OF CREB1, ENZYME REGULATION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11050006;
RA   Verploegen S., Lammers J.-W.L., Koenderman L., Coffer P.J.;
RT   "Identification and characterization of CKLiK, a novel granulocyte
RT   Ca++/calmodulin-dependent protein kinase.";
RL   Blood 96:3215-3223(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, PHOSPHORYLATION AT THR-180, PHOSPHORYLATION BY CAMKK1 AND
RP   CAMKK2, MUTAGENESIS OF THR-180, AND TISSUE SPECIFICITY.
RX   PubMed=12935886; DOI=10.1016/S0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15840691; DOI=10.1182/blood-2004-09-3755;
RA   Verploegen S., Ulfman L., van Deutekom H.W., van Aalst C., Honing H.,
RA   Lammers J.W., Koenderman L., Coffer P.J.;
RT   "Characterization of the role of CaMKI-like kinase (CKLiK) in human
RT   granulocyte function.";
RL   Blood 106:1076-1083(2005).
RN   [8]
RP   FUNCTION IN CREB1 ACTIVATION, SUBCELLULAR LOCATION, DEVELOPMENTAL
RP   STAGE, INDUCTION BY KCL, AND MUTAGENESIS OF LYS-52 AND THR-180.
RX   PubMed=16324104; DOI=10.1111/j.1460-9568.2005.04463.x;
RA   Sakagami H., Kamata A., Nishimura H., Kasahara J., Owada Y.,
RA   Takeuchi Y., Watanabe M., Fukunaga K., Kondo H.;
RT   "Prominent expression and activity-dependent nuclear translocation of
RT   Ca2+/calmodulin-dependent protein kinase Idelta in hippocampal
RT   neurons.";
RL   Eur. J. Neurosci. 22:2697-2707(2005).
RN   [9]
RP   FUNCTION IN DENDTRITIC GROWTH, AND DEVELOPMENTAL STAGE.
RX   PubMed=17056143; DOI=10.1016/j.neures.2006.09.013;
RA   Kamata A., Sakagami H., Tokumitsu H., Owada Y., Fukunaga K., Kondo H.;
RT   "Spatiotemporal expression of four isoforms of Ca2+/calmodulin-
RT   dependent protein kinase I in brain and its possible roles in
RT   hippocampal dendritic growth.";
RL   Neurosci. Res. 57:86-97(2007).
RN   [10]
RP   REVIEW ON FUNCTION IN NEURONAL PLASTICITY.
RX   PubMed=18817731; DOI=10.1016/j.neuron.2008.08.021;
RA   Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A.,
RA   Soderling T.R.;
RT   "Calmodulin-kinases: modulators of neuronal development and
RT   plasticity.";
RL   Neuron 59:914-931(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122 AND THR-180, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-113, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-333 IN COMPLEX WITH
RP   INHIBITOR.
RA   Debreczeni J.E., Rellos P., Fedorov O., Niesen F.H., Bhatia C.,
RA   Shrestha L., Salah E., Smee C., Colebrook S., Berridge G., Gileadi O.,
RA   Bunkoczi G., Ugochukwu E., Pike A.C.W., Von Delft F., Knapp S.,
RA   Sundstrom M., Weigelt J., Arrowsmith C.H., Edwards A.;
RT   "Crystal structure of human calmodulin-dependent protein kinase 1D.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-66.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that
CC       operates in the calcium-triggered CaMKK-CaMK1 signaling cascade
CC       and, upon calcium influx, activates CREB-dependent gene
CC       transcription, regulates calcium-mediated granulocyte function and
CC       respiratory burst and promotes basal dendritic growth of
CC       hippocampal neurons. In neutrophil cells, required for cytokine-
CC       induced proliferative responses and activation of the respiratory
CC       burst. Activates the transcription factor CREB1 in hippocampal
CC       neuron nuclei. May play a role in apoptosis of erythroleukemia
CC       cells. In vitro, phosphorylates transcription factor CREM isoform
CC       Beta. {ECO:0000269|PubMed:11050006, ECO:0000269|PubMed:15840691,
CC       ECO:0000269|PubMed:16324104, ECO:0000269|PubMed:17056143}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:12935886}.
CC   -!- ENZYME REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves
CC       intrasteric autoinhibition and allows phosphorylation of Thr-180
CC       within the activation loop by CaMKK1 or CaMKK2. Phosphorylation of
CC       Thr-180 results in several fold increase in total activity. Unlike
CC       CaMK4, may be unable to exhibit autonomous activity after
CC       Ca(2+)/calmodulin activation. {ECO:0000269|PubMed:11050006,
CC       ECO:0000269|PubMed:12935886}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus
CC       {ECO:0000305}. Note=Predominantly cytoplasmic. Nuclear
CC       localization increases upon activation by KCl treatment in
CC       hippocampal neurons.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IU85-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IU85-2; Sequence=VSP_012135;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly and mostly expressed
CC       in polymorphonuclear leukocytes (neutrophilic and eosinophilic
CC       granulocytes) while little or no expression is observed in
CC       monocytes and lymphocytes. {ECO:0000269|PubMed:11050006,
CC       ECO:0000269|PubMed:12935886, ECO:0000269|PubMed:15840691}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during hippocampal formation with
CC       high expression in the pyramidal cell layers.
CC       {ECO:0000269|PubMed:16324104, ECO:0000269|PubMed:17056143}.
CC   -!- INDUCTION: Expression increases upon treatment of EC cells with
CC       DMSO and retinoic acid. Induced by KCL in PC12 cells.
CC       {ECO:0000269|PubMed:16324104}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin
CC       binding region and interacts in the inactive folded state with the
CC       catalytic domain as a pseudosubstrate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF286366; AAG00534.1; -; mRNA.
DR   EMBL; AB081726; BAC19846.1; -; mRNA.
DR   EMBL; EF444962; ACA05959.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAI14410.1; -; Genomic_DNA.
DR   EMBL; AL512284; CAI14410.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAI14410.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAI14410.1; JOINED; Genomic_DNA.
DR   EMBL; AL512284; CAH71693.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAH71693.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAH71693.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAH71693.1; JOINED; Genomic_DNA.
DR   EMBL; AL512284; CAH71694.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAH71694.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAH71694.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAH71694.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAH74035.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAH74035.1; JOINED; Genomic_DNA.
DR   EMBL; AL512284; CAH74035.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAH74035.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAH74036.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAH74036.1; JOINED; Genomic_DNA.
DR   EMBL; AL512284; CAH74036.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAH74036.1; JOINED; Genomic_DNA.
DR   EMBL; AL731559; CAI14675.1; -; Genomic_DNA.
DR   EMBL; AL391314; CAI14675.1; JOINED; Genomic_DNA.
DR   EMBL; AL512284; CAI14675.1; JOINED; Genomic_DNA.
DR   EMBL; AL512783; CAI14675.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86314.1; -; Genomic_DNA.
DR   EMBL; BC035745; AAH35745.1; -; mRNA.
DR   CCDS; CCDS7091.1; -. [Q8IU85-1]
DR   CCDS; CCDS7092.1; -. [Q8IU85-2]
DR   RefSeq; NP_065130.1; NM_020397.3. [Q8IU85-2]
DR   RefSeq; NP_705718.1; NM_153498.3. [Q8IU85-1]
DR   UniGene; Hs.600547; -.
DR   UniGene; Hs.659517; -.
DR   PDB; 2JC6; X-ray; 2.30 A; A/C=1-333.
DR   PDBsum; 2JC6; -.
DR   ProteinModelPortal; Q8IU85; -.
DR   SMR; Q8IU85; -.
DR   BioGrid; 121382; 35.
DR   IntAct; Q8IU85; 8.
DR   STRING; 9606.ENSP00000368124; -.
DR   BindingDB; Q8IU85; -.
DR   ChEMBL; CHEMBL5073; -.
DR   DrugBank; DB08454; N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE.
DR   GuidetoPHARMACOLOGY; 1953; -.
DR   iPTMnet; Q8IU85; -.
DR   PhosphoSitePlus; Q8IU85; -.
DR   BioMuta; CAMK1D; -.
DR   DMDM; 56404610; -.
DR   EPD; Q8IU85; -.
DR   MaxQB; Q8IU85; -.
DR   PaxDb; Q8IU85; -.
DR   PeptideAtlas; Q8IU85; -.
DR   PRIDE; Q8IU85; -.
DR   DNASU; 57118; -.
DR   Ensembl; ENST00000378845; ENSP00000368122; ENSG00000183049. [Q8IU85-2]
DR   Ensembl; ENST00000619168; ENSP00000478874; ENSG00000183049. [Q8IU85-1]
DR   GeneID; 57118; -.
DR   KEGG; hsa:57118; -.
DR   UCSC; uc001iln.4; human. [Q8IU85-1]
DR   CTD; 57118; -.
DR   DisGeNET; 57118; -.
DR   GeneCards; CAMK1D; -.
DR   HGNC; HGNC:19341; CAMK1D.
DR   HPA; HPA007266; -.
DR   MIM; 607957; gene.
DR   neXtProt; NX_Q8IU85; -.
DR   OpenTargets; ENSG00000183049; -.
DR   PharmGKB; PA134992438; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118944; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG108055; -.
DR   InParanoid; Q8IU85; -.
DR   KO; K08794; -.
DR   OMA; TGHTGSK; -.
DR   OrthoDB; EOG091G0HK9; -.
DR   PhylomeDB; Q8IU85; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   SignaLink; Q8IU85; -.
DR   SIGNOR; Q8IU85; -.
DR   ChiTaRS; CAMK1D; human.
DR   EvolutionaryTrace; Q8IU85; -.
DR   GenomeRNAi; 57118; -.
DR   PRO; PR:Q8IU85; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000183049; -.
DR   CleanEx; HS_CAMK1D; -.
DR   ExpressionAtlas; Q8IU85; baseline and differential.
DR   Genevisible; Q8IU85; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:UniProtKB.
DR   GO; GO:0060267; P:positive regulation of respiratory burst; IMP:UniProtKB.
DR   GO; GO:0050773; P:regulation of dendrite development; IMP:UniProtKB.
DR   GO; GO:0071622; P:regulation of granulocyte chemotaxis; IMP:UniProtKB.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Calcium; Calmodulin-binding; Complete proteome; Cytoplasm;
KW   Inflammatory response; Isopeptide bond; Kinase; Neurogenesis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    385       Calcium/calmodulin-dependent protein
FT                                kinase type 1D.
FT                                /FTId=PRO_0000086082.
FT   DOMAIN       23    279       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      29     37       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      279    319       Autoinhibitory domain. {ECO:0000250}.
FT   REGION      299    320       Calmodulin-binding. {ECO:0000250}.
FT   MOTIF       318    324       Nuclear export signal. {ECO:0000250}.
FT   COMPBIAS    326    364       Ser-rich.
FT   ACT_SITE    144    144       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      52     52       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     180    180       Phosphothreonine; by CaMKK1 and CaMKK2.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:12935886}.
FT   CROSSLNK    113    113       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ     348    385       LAPSTLCSFISSSSGVSGVGAERRPRPTTVTAVHSGSK ->
FT                                AYVAKPESLS (in isoform 2).
FT                                {ECO:0000303|PubMed:11050006}.
FT                                /FTId=VSP_012135.
FT   VARIANT      66     66       I -> M (in dbSNP:rs34194224).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040599.
FT   MUTAGEN      52     52       K->A: Catalytically inactive form.
FT                                {ECO:0000269|PubMed:16324104}.
FT   MUTAGEN     180    180       T->A: Loss of ionomycin-induced
FT                                activation. {ECO:0000269|PubMed:12935886,
FT                                ECO:0000269|PubMed:16324104}.
FT   STRAND       13     15       {ECO:0000244|PDB:2JC6}.
FT   HELIX        19     22       {ECO:0000244|PDB:2JC6}.
FT   STRAND       23     31       {ECO:0000244|PDB:2JC6}.
FT   STRAND       36     42       {ECO:0000244|PDB:2JC6}.
FT   TURN         43     45       {ECO:0000244|PDB:2JC6}.
FT   STRAND       48     55       {ECO:0000244|PDB:2JC6}.
FT   HELIX        66     75       {ECO:0000244|PDB:2JC6}.
FT   STRAND       84     89       {ECO:0000244|PDB:2JC6}.
FT   STRAND       91     99       {ECO:0000244|PDB:2JC6}.
FT   HELIX       106    112       {ECO:0000244|PDB:2JC6}.
FT   HELIX       118    137       {ECO:0000244|PDB:2JC6}.
FT   HELIX       147    149       {ECO:0000244|PDB:2JC6}.
FT   STRAND      150    156       {ECO:0000244|PDB:2JC6}.
FT   STRAND      161    163       {ECO:0000244|PDB:2JC6}.
FT   HELIX       190    193       {ECO:0000244|PDB:2JC6}.
FT   HELIX       201    216       {ECO:0000244|PDB:2JC6}.
FT   HELIX       226    235       {ECO:0000244|PDB:2JC6}.
FT   TURN        242    247       {ECO:0000244|PDB:2JC6}.
FT   HELIX       250    259       {ECO:0000244|PDB:2JC6}.
FT   TURN        264    266       {ECO:0000244|PDB:2JC6}.
FT   HELIX       270    273       {ECO:0000244|PDB:2JC6}.
FT   HELIX       277    280       {ECO:0000244|PDB:2JC6}.
FT   HELIX       290    300       {ECO:0000244|PDB:2JC6}.
FT   HELIX       305    311       {ECO:0000244|PDB:2JC6}.
SQ   SEQUENCE   385 AA;  42914 MW;  717467D019E30FC9 CRC64;
     MARENGESSS SWKKQAEDIK KIFEFKETLG TGAFSEVVLA EEKATGKLFA VKCIPKKALK
     GKESSIENEI AVLRKIKHEN IVALEDIYES PNHLYLVMQL VSGGELFDRI VEKGFYTEKD
     ASTLIRQVLD AVYYLHRMGI VHRDLKPENL LYYSQDEESK IMISDFGLSK MEGKGDVMST
     ACGTPGYVAP EVLAQKPYSK AVDCWSIGVI AYILLCGYPP FYDENDSKLF EQILKAEYEF
     DSPYWDDISD SAKDFIRNLM EKDPNKRYTC EQAARHPWIA GDTALNKNIH ESVSAQIRKN
     FAKSKWRQAF NATAVVRHMR KLHLGSSLDS SNASVSSSLS LASQKDCLAP STLCSFISSS
     SGVSGVGAER RPRPTTVTAV HSGSK
//
